Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Total Current Assets
Mereo Biopharma Group PLC
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Total Current Assets
£62.1m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Total Current Assets
$315.1m
|
CAGR 3-Years
204%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Total Current Assets
$275.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Total Current Assets
$516m
|
CAGR 3-Years
34%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Total Current Assets
£528.8m
|
CAGR 3-Years
51%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Total Current Assets
£277.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
See Also
What is Mereo Biopharma Group PLC's Total Current Assets?
Total Current Assets
62.1m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Total Current Assets amounts to 62.1m GBP.
What is Mereo Biopharma Group PLC's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
27%
Over the last year, the Total Current Assets growth was -37%. The average annual Total Current Assets growth rates for Mereo Biopharma Group PLC have been 27% over the past three years .